|
Volumn 66, Issue 10 SUPPL. 4, 2006, Pages
|
The need for neuroprotective therapies in Parkinson's disease: A clinical perspective
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LAZABEMIDE;
LEVODOPA;
UBIDECARENONE;
NEUROPROTECTIVE AGENT;
AUTONOMIC DYSFUNCTION;
BODY EQUILIBRIUM;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITION;
DEMENTIA;
DISEASE COURSE;
FALLING;
FOLLOW UP;
FREEZING;
HUMAN;
META ANALYSIS;
MOTOR DYSFUNCTION;
NEUROPROTECTION;
PAIN;
PARKINSON DISEASE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK FACTOR;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SLEEP DISORDER;
SYMPTOMATOLOGY;
SYSTEMATIC REVIEW;
ARTICLE;
CLINICAL PRACTICE;
COGNITIVE DEFECT;
PRACTICE GUIDELINE;
CLINICAL TRIALS;
COGNITION DISORDERS;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
PHYSICIAN'S PRACTICE PATTERNS;
PRACTICE GUIDELINES;
|
EID: 33744990845
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/wnl.66.10_suppl_4.s2 Document Type: Review |
Times cited : (30)
|
References (0)
|